DrugInformer Search


Average User Review Score
* Based on 0 reviews from across the web.

Amitriptyline, sold under the brand name Elavil among others, is a medicine used to treat a number of mental illnesses. This includes major depressive disorder and anxiety disorder, and less commonly attention deficit hyperactivity disorder and bipolar disorder. Other uses include prevention of migraines, treatment of neuropathic pain such as fibromyalgia and postherpetic neuralgia, and less commonly insomnia. It is taken by mouth.

Read more on Wikipedia

  Please use Workbench for in-depth research on Amitril.

* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Amitril

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: None

Posted By sptrout in www.dailystrength.org on March 13, 2014 @ 12:00 am

If you want to try something a little out of the box, ask your doctor about starting your on amitriltyline. Amitriptyline is an old anti-antidepressant, but when given in very low doses has two good ...

Druginformer Identified Side Effects: None

Posted By NordicNINE in forums.webmd.com on June 9, 2009 @ 12:00 am

I'm kinda nervous about taking this. I just starting working a new job 4 weeks ago. It was a contract position that is now over and I'm so glad. It was sitting 8 hours 12am-8am and I was in SO much...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.